Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
04/17/20179:00AMBWParexel International Announces Date of Third Quarter Fiscal Year 2017 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2017 on Wednesday, May 3, 2017 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, May 4, 2017 to discuss the results. To access the webcast... More...>>
04/03/20179:00AMBWPAREXEL Ranked a Top CRO in CenterWatch Global Investigative Site Relationship Survey
Company recognized for sponsor/site relationship quality PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it was named a top contract research organization (CRO) in the CenterWatch 2017 Global Investigative Site Relationship Survey. The survey... More...>>
03/30/20179:00AMBWPAREXEL Launches Patient Sensor Solution to Transform Clinical Trial Data Collection
Comprehensive wearables and sensors solution, powered by the Perceptive MyTrials® Analytics platform, creates greater efficiencies for biopharmaceutical companies PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution... More...>>
03/13/20179:00AMBWPAREXEL Named a FlexJobs Top 100 Company to Watch for Telecommuting and Remote Jobs in 2017
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch for Telecommuting and Remote Jobs in 2017 list for the fourth consecutive year. The list recognizes companies that are telecommuting-friendly... More...>>
02/28/20177:00AMBWPAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer
Appointment Effective June 1, 2017 PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Simon Harford as Senior Vice President and Chief Financial Officer effective June 1, 2017. He will serve on PAREXEL's Business Review Committee, the... More...>>
02/22/201710:00AMBWPAREXEL International to Participate at Cowen & Co. Health Care Conference and Barclays Global Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be participating at two investor conferences in March. Emma Reeve, Corporate Vice President and Interim Chief Financial Officer, will meet with investors at the Cowen and Company Health Care Conference on Monday, March 6, 2017, in Boston... More...>>
02/13/20179:00AMBWPAREXEL Launches ClinPhone RTSM Mobile App to Improve Supply Management and Increase Patient Safety
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone® RTSM (randomization and trial supply management) service. The app is designed to enhance clinical trial supply management processes, increase patient safety, and improve... More...>>
02/09/20174:05PMGLOBEQuotient Limited Announces Appointment of Christopher Lindop as Chief Financial Officer
JERSEY, Channel Islands, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Christopher Lindop as Chief Financial Officer.  Mr. Lindop will commence his new role on February 15, 2017. Mr. Lindop joins Quotient with more... More...>>
02/07/20171:00PMBWPAREXEL International to Present at Leerink Partners Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Leerink Partners Healthcare Conference on Thursday, February 16, 2017, in New York City. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments... More...>>
02/01/201711:18PMBWPAREXEL International Reports Second Quarter Fiscal Year 2017 Results
Second Quarter Fiscal Year 2017 Results (compared to Second Quarter Fiscal Year 2016) Service revenue of $534.4 million, up 3.1% GAAP diluted earnings per share of $0.41, down 43.8%; adjusted earnings per share of $0.85, down 5.6% Gross new business of $971 million, cancellations of $266 million Backlog increased 8.4... More...>>
02/01/20177:00PMBWPAREXEL Announces Definitive Agreement to Acquire The Medical Affairs Company
Acquisition will strengthen and add scale to current commercialization and medical affairs services PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC... More...>>
01/31/201711:00AMBWPAREXEL Recognized as a 2017 “Training Top 125” by Training Magazine
Company acknowledged for excellence in employer-sponsored training and development programs PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has been recognized among top U.S. businesses in Training magazine’s annual “Training Top... More...>>
01/26/20179:00AMBWPAREXEL Expands Managed Access Programs Service Offering
Simplified, end-to-end solution will help biopharmaceutical clients provide compassionate access to their treatments for patients PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an expanded Managed Access Programs service. PAREXEL now offers end-to-end... More...>>
01/19/20173:00PMBWPAREXEL International Announces Date of Second Quarter Fiscal Year 2017 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter Fiscal Year 2017 on Wednesday, February 1, 2017 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, February 2, 2017 to discuss the results. To access... More...>>
12/20/20169:00AMBWPAREXEL International to Present at JP Morgan Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Tuesday, January 10, 2017, in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at... More...>>
12/01/201611:45AMPRNUSLifshitz & Miller Law Firm Announces Investigation of Georgetown Bancorp, Inc., Lattice Semiconductor Corporation, Mallinckro...
Lifshitz & Miller Law Firm Announces Investigation of Georgetown Bancorp, Inc., Lattice Semiconductor Corporation, Mallinckrodt Public Limited Company, Mentor Graphics Corporation, PAREXEL International Corporation, Resource Capital Corp., Southwestern Energy Company and Team Health Holdings, Inc. PR Newswire NEW YORK... More...>>
11/22/201610:09AMBWPAREXEL International Announces $200 Million Accelerated Share Repurchase Program
PAREXEL International Corporation (Nasdaq:PRXL), a leading global biopharmaceutical services provider, announced today that the Company entered into an accelerated share repurchase agreement (ASR) with HSBC Bank USA, National Association, to purchase shares of its common stock for an aggregate purchase price of $200 million... More...>>
11/16/20169:00AMBWPAREXEL International to Participate in Evercore ISI MedTools Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston. Josef von Rickenbach, Chairman and Chief Executive Officer, will participate on Wednesday, November 30, 2016. About PAREXEL InternationalPAREXEL International Corporation is a leading... More...>>
11/15/20163:41PMPRNUSHarwood Feffer LLP Announces Investigation of PAREXEL International Corporation
Harwood Feffer LLP Announces Investigation of PAREXEL International Corporation PR Newswire NEW YORK, Nov. 15, 2016 NEW YORK, Nov. 15, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of PAREXEL International Corporation ("PAREXEL" or the "Company... More...>>
11/14/20165:30PMBWBragar Eagel & Squire, P.C. Is Investigating PAREXEL International Corp. (PRXL) on Behalf of Stockholders & Encourages Invest...
Bragar Eagel & Squire, P.C. is investigating potential claims against PAREXEL International Corporation (NASDAQ:PRXL) concerning possible violations of the federal securities laws. On August 30, 2016, post-market, PAREXEL announced that the Company was postponing the filing of its 2016 Annual Report on Form 10-K after... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V:us D:20170428 00:23:21